BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30574629)

  • 1. Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report.
    Emanuel AJ; Holman N; Presnell SE; Welsh CT; Pai S; Sun S
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):459-463. PubMed ID: 30574629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.
    Tezuka Y; Fukuda M; Watanabe S; Nakano T; Okamoto K; Kuzume K; Yano Y; Eguchi M; Ishimae M; Ishii E; Miyazaki T
    Blood Cells Mol Dis; 2018 Feb; 68():194-199. PubMed ID: 27866810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme Replacement Therapy in a Gaucher Family.
    Erdem N; Buran T; Berber I; Aydogdu I
    J Natl Med Assoc; 2018 Aug; 110(4):330-333. PubMed ID: 30126557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal disease activity in Gaucher disease: criteria for definition.
    Di Rocco M; Andria G; Bembi B; Carubbi F; Giona F; Giuffrida G; Linari S; Sibilio M; Spina V; Cappellini MD
    Mol Genet Metab; 2012 Nov; 107(3):521-5. PubMed ID: 22954583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease.
    Mignot C; Gelot A; De Villemeur TB
    Handb Clin Neurol; 2013; 113():1709-15. PubMed ID: 23622393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cavernoma complicated with biliopatia secondary to type 1 Gaucher disease: report of a Peruvian case].
    Morán-Mariños C; Vilchez-Cornejo J; Quispe-Colquepisco S
    Rev Gastroenterol Peru; 2018; 38(3):280-284. PubMed ID: 30540732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gaucher disease: A review].
    Nguyen Y; Stirnemann J; Belmatoug N
    Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hemorrhage in type 3 Gaucher disease: a case report.
    Vellodi A; Ashworth M; Finnegan N; Wallis C
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S329-31. PubMed ID: 20689991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varied autopsy findings in five treated patients with Gaucher disease and parkinsonism include the absence of Gaucher cells.
    Monestime G; Borger DK; Kim J; Lopez G; Allgaeuer M; Jain D; Vortmeyer A; Wang HW; Sidransky E
    Mol Genet Metab; 2016 May; 118(1):55-9. PubMed ID: 26992326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural features of gaucher disease treated with enzyme replacement therapy presenting as mesenteric mass lesions.
    Fowler DJ; Weber MA; Anderson G; Malone M; Sebire NJ; Vellodi A
    Fetal Pediatr Pathol; 2006; 25(5):241-8. PubMed ID: 17438664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.
    Tsuboi K; Iida S; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Komatsu H; Banno S; Wakita A; Nitta M; Ueda R
    Int J Hematol; 2001 Apr; 73(3):356-62. PubMed ID: 11345203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process.
    Hůlková H; Ledvinová J; Poupetová H; Kohout A; Malinová V; Elleder M
    J Inherit Metab Dis; 2009 Aug; 32(4):551-9. PubMed ID: 19557545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme therapy in Gaucher disease type 2: an autopsy case.
    Takahashi T; Yoshida Y; Sato W; Yano T; Shoji Y; Sawaishi Y; Sakuma I; Sashi T; Enomoto K; Ida H; Takada G
    Tohoku J Exp Med; 1998 Oct; 186(2):143-9. PubMed ID: 10223617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large soft-tissue masses in an adult patient with Gaucher disease.
    Mahajan N; Brynes R; Yano S
    J Inherit Metab Dis; 2016 Nov; 39(6):887-888. PubMed ID: 27503099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholelithiasis in a patient with type 2 Gaucher disease.
    Migita M; Kumasaka S; Matsumoto T; Tajima H; Ueda T; Yamataka A
    J Nippon Med Sch; 2014; 81(1):40-2. PubMed ID: 24614394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.